CBI offers a range of infection modeling for the purposes of identification of novel anti-infective agents, particularly MRSA, vancomycin-resistant staph, and gram positive organisms. Our senior scientist for anti-infective modeling is Dr. James Christenson, formerly of Hoffmann LaRoche in Nutley NJ, who was the leader in the discovery and development of Rochefin and other block buster antibiotics.
- Mouse protection test
- Neutropenic thigh abscess
- Dermal inflammation and abscessation
- Bacterial pneumonia
- Cytodex bead subcutaneous abscess
- Bacterial endocarditis
- Sepsis; Clostridium diarrhea
- Mini Tox and Mini PK studies to support efficacy studies
- ATCC and custom bacterial strains available
For further information, contact CBI.